{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15092", "batch_size": 260, "batch_pos": 9, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports a statement factually.", "method": "llm_batch", "batch_id": "batch_2_15020", "batch_size": 260, "batch_pos": 243, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Lacks a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_15688", "batch_size": 260, "batch_pos": 178, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17420", "batch_size": 260, "batch_pos": 167, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports discussions but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_1504", "batch_size": 260, "batch_pos": 164, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_14128", "batch_size": 260, "batch_pos": 134, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation about risk, cases, or capability.", "method": "llm_batch", "batch_id": "batch_7_17788", "batch_size": 260, "batch_pos": 114, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "The segment describes company discussions related to vaccine development ('in discussions with the U.S. government on advancing our pandemic flu candidate'), describing a capability/preparedness without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_1004", "batch_size": 260, "batch_pos": 232, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
